Evidence map›Paper›PMID 28964259›Full record

ReviewGenome medicine2017

Three-dimensional genome architecture and emerging technologies: looping in disease.

Arpit Mishra, R David Hawkins

Open access · goldAbstract readReview
In one paragraph

Review in Genome medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Clinical and experimental treatment of type 1 diabetes.Clinical and experimental immunology · 2022
    Review
  12. Review
  13. Molecular Modelling Hurdle in the Next-Generation Sequencing Era.International journal of molecular sciences · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Epigenetic Alterations in Inborn Errors of Immunity.Journal of clinical medicine · 2022
    Review
  18. Article
  19. Article
  20. Regulation of Gene Expression by Telomere Position Effect.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Arpit MishraDivision of Medical Genetics, Department of Medicine, Department of Genome Sciences, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, WA, 98195-5065, USA.
R David HawkinsDivision of Medical Genetics, Department of Medicine, Department of Genome Sciences, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, WA, 98195-5065, USA. rdhawk@uw.edu.
University of Washington · US

Funding

Functional assessment of distal regulatory SNPs associated with type 1 diabetes.R01DK103667 · NIDDK · UNIVERSITY OF WASHINGTON · PI HAWKINS, RAYMOND DAVID · 2015 to 2019
$2.5M
Functional validation of Rheumatoid Arthritis-associated distal regulatory SNPs iR01AR065952 · NIAMS · UNIVERSITY OF WASHINGTON · PI HAWKINS, RAYMOND DAVID · 2015 to 2018
$1.8M
NIAMS NIH HHS R01 AR065952NIDDK NIH HHS R01 DK103667
6 · The paper itself

Abstract

Genome compaction is a universal feature of cells and has emerged as a global regulator of gene expression. Compaction is maintained by a multitude of architectural proteins, long non-coding RNAs (lncRNAs), and regulatory DNA. Each component comprises interlinked regulatory circuits that organize the genome in three-dimensional (3D) space to manage gene expression. In this review, we update the current state of 3D genome catalogues and focus on how recent technological advances in 3D genomics are leading to an enhanced understanding of disease mechanisms. We highlight the use of genome-wide chromatin conformation capture (Hi-C) coupled with oligonucleotide capture technology (capture Hi-C) to map interactions between gene promoters and distal regulatory elements such as enhancers that are enriched for disease variants from genome-wide association studies (GWASs). We discuss how aberrations in architectural units are associated with various pathological outcomes, and explore how recent advances in genome and epigenome editing show great promise for a systematic understanding of complex genetic disorders. Our growing understanding of 3D genome architecture-coupled with the ability to engineer changes in it-may create novel therapeutic opportunities.

Indexed as

Genetic Diseases, InbornGenetic TechniquesGenome, HumanRegulatory Sequences, Ribonucleic AcidChromatinChromosome MappingGene Expression RegulationHumansIn Situ Hybridization, FluorescenceNucleic Acid ConformationPromoter Regions, GeneticChromatinRegulatory Sequences, Ribonucleic Acid

Identifiers

PMID28964259
PMCPMC5623062
OpenAlexW2758862582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.